EGFR and neoplasm: To test the effectiveness of the synthesized agents as targeted molecular probes in detecting EGFR-positive tumors, in vivo tumor-targeting MR imaging of the contrast agents was performed on SCID mice bearing subcutaneous MDA-MB-231 and U138 MG tumor xenografts at different times.